Healthcare -
Biotechnology - NASDAQ - US
$ 3.97
-2.7 %
$ 38.7 M
Market Cap
-0.11
P/E
BLUE - STOCK-BASED COMPENSATION
Stock-based Compensation BLUE - bluebird bio, Inc.
19.4 M
LAST VALUE
-61.03%
2 YEAR CAGR
-29.41%
5 YEAR CAGR
11.59%
10 YEAR CAGR